Growth Metrics

Standard Biotools (LAB) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23.43%
Dec 31, 2025 -10.05%
Sep 30, 2025 -18.33%
Jun 30, 2025 -16.80%
Mar 31, 2025 -21.26%
Dec 31, 2024 418.62%
Sep 30, 2024 471.49%
Jun 30, 2024 550.02%
Mar 31, 2024 694.23%
Dec 31, 2023 -81.73%
Sep 30, 2023 -109.92%
Jun 30, 2023 -202.74%
Mar 31, 2023 -539.35%
Dec 31, 2022 -186.12%
Sep 30, 2022 -163.17%
Jun 30, 2022 -134.22%
Mar 31, 2022 -82.01%
Dec 31, 2021 -31.97%
Sep 30, 2021 -34.64%
Jun 30, 2021 -17.53%
Mar 31, 2021 -13.12%
Dec 31, 2020 -9.48%
Sep 30, 2020 -6.54%
Jun 30, 2020 -23.12%
Mar 31, 2020 -22.36%
Dec 31, 2019 113.01%
Sep 30, 2019 625.53%
Jun 30, 2019 395.65%
Mar 31, 2019 275.19%
Dec 31, 2018 133.12%
Sep 30, 2018 -42.64%
Jun 30, 2018 5,475.15%
Mar 31, 2018 6,799.86%
Dec 31, 2017 -41.89%
Sep 30, 2017 -42.52%
Jun 30, 2017 24.48%
Mar 31, 2017 18.08%
Dec 31, 2016 -53.67%
Sep 30, 2016 -45.24%
Jun 30, 2016 -100.64%
Mar 31, 2016 -100.62%
Dec 31, 2015 -23.61%
Sep 30, 2015 -19.69%
Jun 30, 2015 -17.68%
Mar 31, 2015 -14.92%
Dec 31, 2014 56.01%
Sep 30, 2014 59.32%
Jun 30, 2014 64.48%
Mar 31, 2014 67.22%
Dec 31, 2013 -4.22%
Sep 30, 2013 -5.50%
Jun 30, 2013 101.11%
Mar 31, 2013 92.92%
Dec 31, 2012 76.91%
Sep 30, 2012 73.55%
Jun 30, 2012 -21.48%
Dec 31, 2011 130.08%